Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

BioCorRx (BICX) Return on Capital Employed (2016 - 2025)

BioCorRx (BICX) has disclosed Return on Capital Employed for 15 consecutive years, with 2.67% as the latest value for Q4 2025.

  • Quarterly Return on Capital Employed rose 201.0% to 2.67% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 2.67% through Dec 2025, up 201.0% year-over-year, with the annual reading at 0.69% for FY2025, 3.0% up from the prior year.
  • Return on Capital Employed hit 2.67% in Q4 2025 for BioCorRx, up from 0.68% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 9.98% in Q2 2021 to a low of 0.52% in Q1 2025.
  • Historically, Return on Capital Employed has averaged 1.88% across 5 years, with a median of 0.88% in 2023.
  • Biggest five-year swings in Return on Capital Employed: surged 17503bps in 2021 and later plummeted -854bps in 2022.
  • Year by year, Return on Capital Employed stood at 1.73% in 2021, then tumbled by -41bps to 1.03% in 2022, then tumbled by -38bps to 0.63% in 2023, then increased by 5bps to 0.67% in 2024, then surged by 301bps to 2.67% in 2025.
  • Business Quant data shows Return on Capital Employed for BICX at 2.67% in Q4 2025, 0.68% in Q3 2025, and 0.66% in Q2 2025.